Document is current
Any future updates will be listed below
-
Authors
Si, Shuqing https://orcid.org/0009-0006-6095-254X
Bi, Anbreen
Yu, Zhaoying
See, Cheryl https://orcid.org/0000-0003-2135-5495
Kelly, Sinead
Ambrogi, Sonia https://orcid.org/0000-0002-2897-358X
Arango, Celso https://orcid.org/0000-0003-3382-4754
Baeza, Inmaculada
Banaj, Nerisa https://orcid.org/0000-0002-6317-8549
Berk, Michael
Castro-Fornieles, Josefina https://orcid.org/0000-0003-0632-2687
Crespo-Facorro, Benedicto
Crouse, Jacob J. https://orcid.org/0000-0002-3805-2936
Díaz-Caneja, Covadonga M. https://orcid.org/0000-0001-8538-3175
Fett, Anne-Kathrin https://orcid.org/0000-0003-0282-273X
Fortea, Adriana https://orcid.org/0000-0003-3681-0841
Frangou, Sophia
Goldstein, Benjamin I.
Hickie, Ian B. https://orcid.org/0000-0001-8832-9895
Janssen, Joost https://orcid.org/0000-0001-7613-2067
Kennedy, Kody G. https://orcid.org/0000-0002-4510-188X
Krabbendam, Lydia
Kyriakopoulos, Marinos
MacIntosh, Bradley J. https://orcid.org/0000-0001-7300-2355
Morgado, Pedro https://orcid.org/0000-0003-3880-3258
Nerland, Stener https://orcid.org/0000-0001-8771-8856
Pascual-Diaz, Saül https://orcid.org/0000-0001-5871-5867
Picó-Pérez, Maria https://orcid.org/0000-0002-1573-2445
Piras, Fabrizio https://orcid.org/0000-0003-3566-5494
Rund, Bjørn Rishovd
de la Serna, Elena
Spalletta, Gianfranco
Sugranyes, Gisela https://orcid.org/0000-0002-2545-7862
Suo, Chao https://orcid.org/0000-0002-9358-6690
Tordesillas-Gutiérrez, Diana
Vecchio, Daniela https://orcid.org/0000-0001-8428-7376
Radua, Joaquim
McGuire, Philip https://orcid.org/0000-0003-4381-0532
Thomopoulos, Sophia I.
Jahanshad, Neda
Thompson, Paul M.
Barth, Claudia https://orcid.org/0000-0001-6544-0945
Agartz, Ingrid
James, Anthony https://orcid.org/0000-0002-2742-8328
Kempton, Matthew J. https://orcid.org/0000-0003-3541-9947
- License Information
-
More Information
Article History
Received: 13 June 2023
Revised: 7 November 2023
Accepted: 27 November 2023
First Online: 10 January 2024
Competing interests
: PT and NJ were funded in part by Biogen, Inc., for research unrelated to this manuscript. GS has received speaker fees from Angelini Pharma for a topic unrelated to this manuscript. AF has received educational support from Otsuka-Lundbeck, Janssen Cilag and Rovi, unrelated to this manuscript. CA has been a consultant to or has received honoraria or grants from Acadia, Angelini, Biogen, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Menarini, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plow, Sumitomo Dainippon Pharma, Sunovion and Takeda. CDC has received honoraria from Exeltis and Angelini unrelated to this manuscript. IB has received honoraria and travel support from Angelini, Otsuka-Lundbeck and Janssen. IA has received speaker’s honorarium from Lundbeck. PM has received in the past 3 years grants, CME-related honoraria, or consulting fees from Angelini, AstraZeneca, Bial, Biogen, DGS-Portugal, FCT, FLAD, Janssen-Cilag, Gulbenkian Foundation, Lundbeck, Springer Healthcare, Tecnimede, Viatris and 2CA-Braga. IBH is the Co-Director, Health and Policy at the Brain and Mind Centre (BMC) University of Sydney, Australia. The BMC operates an early-intervention youth service at Camperdown under contract to headspace. IBH has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca, Janssen Cilag) projects focused on the identification and better management of anxiety and depression. He is the Chief Scientific Advisor to, and a 3.2% equity shareholder in, InnoWell Pty Ltd, which aims to transform mental health services through the use of innovative technologies.
